Taipei, Feb. 17 (CNA) The United States Patent Trial and Appeal Board has handed a win to Chinese-American synthetic biologist Feng Zhang (張鋒) and his team from the Massachusetts Institute of Technology (MIT) in a dispute over patents of the gene editing technology known as CRISPR.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
MOFA says it strongly believes Haiti unrest will not change Taiwan ties
03/19/2024 04:44 PM - Society
Argentine garlic, Ukrainian sorghum among items seized at border
03/19/2024 02:54 PM - Business
Taiwan shares close down 0.11%
03/19/2024 02:15 PM - Politics
Vice President-elect Hsiao in the Czech Republic: MOFA
03/19/2024 02:08 PM - Society
Taiwan Railway to add 26 train services for Dajia Mazu Pilgrimage
03/19/2024 12:26 PM